Literature DB >> 10407177

Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex.

H Tohgi1, K Utsugisawa, Y Nagane, M Yoshimura, Y Genda, M Ukitsu.   

Abstract

Methylation status of cytosines and its changes with age in the promoter region (-226 approximately -101) of the amyloid precursor protein (APP) was analyzed using bisulfite genomic sequencing in the cerebral cortex of human autopsy brain. Cytosines at 13 locations were methylated in at least one of the cases studied. Methylcytosines at these locations was more frequent in cases </=70 years old (26%) than in cases >70 years old (8%) (p<0.05). Cytosines at -207, -204, -200, and -182 are frequently methylated, and the frequency of methylcytosine in these locations was significantly higher in cases </=70 years old (55%) than cases >70 years old (5%) (p<0.01). These cytosines constituted one of the 9-bp-long GC-rich elements (GGGCGC G/A GG) or an 11-bp inverted repeat (GGCCGT CGGCC). The present findings indicate that some cytosines, particularly those at -207 approximately -182, in the promoter region of the APP gene are frequently methylated and suggest that their demethylation with age may have some significance in the development of Abeta deposition in the aged brain. The relative importance of these elements in the total promoter activity of the APP gene remains to be definitively established. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407177     DOI: 10.1016/s0169-328x(99)00163-1

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  62 in total

1.  Genetic variation in imprinted genes is associated with risk of late-onset Alzheimer's disease.

Authors:  Mamoonah Chaudhry; Xingbin Wang; Mikhil N Bamne; Shahida Hasnain; F Yesim Demirci; Oscar L Lopez; M Ilyas Kamboh
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Epigenetics in the human brain.

Authors:  Isaac Houston; Cyril J Peter; Amanda Mitchell; Juerg Straubhaar; Evgeny Rogaev; Schahram Akbarian
Journal:  Neuropsychopharmacology       Date:  2012-05-30       Impact factor: 7.853

3.  Formaldehyde, Epigenetics, and Alzheimer's Disease.

Authors:  Fei Wang; Danqi Chen; Peipei Wu; Catherine Klein; Chunyuan Jin
Journal:  Chem Res Toxicol       Date:  2019-04-19       Impact factor: 3.739

Review 4.  Alzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigenetics.

Authors:  Kelly M Bakulski; Laura S Rozek; Dana C Dolinoy; Henry L Paulson; Howard Hu
Journal:  Curr Alzheimer Res       Date:  2012-06       Impact factor: 3.498

5.  Does SCFD1 rs10139154 Polymorphism Decrease Alzheimer's Disease Risk?

Authors:  Polyxeni Stamati; Vasileios Siokas; Athina-Maria Aloizou; Emmanouil Karampinis; Stylianos Arseniou; Valerii N Rakitskii; Aristidis Tsatsakis; Demetrios A Spandidos; Illana Gozes; Panayiotis D Mitsias; Dimitrios P Bogdanos; Georgios M Hadjigeorgiou; Efthimios Dardiotis
Journal:  J Mol Neurosci       Date:  2019-07-02       Impact factor: 3.444

Review 6.  DNA methylation impacts on learning and memory in aging.

Authors:  Liang Liu; Thomas van Groen; Inga Kadish; Trygve O Tollefsbol
Journal:  Neurobiol Aging       Date:  2007-09-11       Impact factor: 4.673

Review 7.  DNA hypomethylation in the origin and pathogenesis of human diseases.

Authors:  Igor P Pogribny; Frederick A Beland
Journal:  Cell Mol Life Sci       Date:  2009-03-27       Impact factor: 9.261

8.  Epigenetic changes in the progression of Alzheimer's disease.

Authors:  M A Bradley-Whitman; M A Lovell
Journal:  Mech Ageing Dev       Date:  2013-09-03       Impact factor: 5.432

Review 9.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

10.  5-Lipoxygenase and epigenetic DNA methylation in aging cultures of cerebellar granule cells.

Authors:  M Imbesi; S Dzitoyeva; L W Ng; H Manev
Journal:  Neuroscience       Date:  2009-09-22       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.